Use of incretin-based medications: what do current international recommendations suggest with respect to GLP-1 receptor agonists and DPP-4 inhibitors?
Melanie J. Davies, Cristina Bianchi, Stefano Del Prato
Topics & Concepts
IncretinMedicineHypoglycemiaIntensive care medicineGlycemicType 2 diabetesDiabetes mellitusClinical trialPharmacologyInternal medicineEndocrinologyDiabetes Treatment and ManagementPharmacology and Obesity TreatmentMetabolism, Diabetes, and Cancer